Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial
Galindo et al.
The finding, in our words
In adults with type 2 diabetes and end-stage kidney failure on haemodialysis, real-time continuous glucose monitoring improved time in glycaemic target range and reduced time above range compared with capillary blood glucose testing, while time below range remained minimal and unchanged. This suggests patient-centric glucose monitoring may benefit this high-risk population, though further studies are needed to confirm these benefits.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
Over-the-counter continuous glucose monitors demonstrated reasonable agreement with overall capillary blood glucose trends in individuals without diabetes, yielding an overall mean absolute relative difference of 12.9%. However, sensor accuracy decreased following carbohydrate consumption, suggesting caution is required when using these devices for diagnostic cut-offs or exact-value monitoring.
Prakash et al., Journal of diabetes science and technology (paywalled) · source ↗
Real-time continuous glucose monitoring proved accurate and reliable in 35 children with diabetic ketoacidosis in a paediatric intensive care unit, with 95% of readings falling within clinically acceptable zones when compared with point-of-care capillary and serum glucose measurements. Acidosis did not impair accuracy, supporting CGM use in acute paediatric care.
Pott et al., Journal of diabetes science and technology (paywalled) · source ↗
A redundant continuous glucose sensor with two working electrodes achieved better accuracy (mean absolute relative deviation 10.1%) and more display time than either electrode alone in adults with type 1 diabetes over seven days. Its performance compared favourably with existing high-quality sensors.
Sharifi et al., Journal of diabetes science and technology (paywalled) · source ↗
In adults with type 1 diabetes, Dexcom G7 and FreeStyle Libre 3 showed high accuracy during physical activity, whereas the Simplera system was less accurate; this matters for selecting devices in decentralised monitoring.
Sanfilippo et al., Diabetes, obesity & metabolism · source ↗
Non-invasive and minimally invasive blood glucose monitoring techniques enable continuous tracking without pain, although traditional invasive methods retain superior accuracy relative to reference blood glucose measurements. Emerging wearable biosensors and alternative matrices such as interstitial fluid, saliva, and sweat offer promising solutions to enhance patient compliance and quality of life.
Ahmadian et al., Journal of medical engineering & technology (paywalled) · source ↗